Timber Hill’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Hold |
0
| – | – | – | 322 |
|
|
2017
Q4 | – | Sell |
-7,606
| Closed | -$708K | – | 444 |
|
|
2017
Q3 | $708K | Buy |
7,606
+789
| +12% | +$73.4K | 0.07% | 91 |
|
|
2017
Q2 | $619K | Sell |
6,817
-2,520
| -27% | -$229K | 0.02% | 127 |
|
|
2017
Q1 | $820K | Sell |
9,337
-4,187
| -31% | -$368K | 0.01% | 218 |
|
|
2016
Q4 | $1.12M | Sell |
13,524
-1,539
| -10% | -$127K | 0.01% | 172 |
|
|
2016
Q3 | $1.39M | Buy |
15,063
+5,138
| +52% | +$475K | 0.01% | 120 |
|
|
2016
Q2 | $772K | Buy |
+9,925
| New | +$772K | ﹤0.01% | 211 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 526 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 556 |
|
|
2015
Q3 | – | Sell |
-3,038
| Closed | -$416K | – | 630 |
|
|
2015
Q2 | $416K | Buy |
+3,038
| New | +$416K | ﹤0.01% | 424 |
|
|
2015
Q1 | – | Sell |
-9,448
| Closed | -$854K | – | 687 |
|
|
2014
Q4 | $854K | Buy |
+9,448
| New | +$854K | ﹤0.01% | 262 |
|
|
2014
Q3 | – | Sell |
-5,734
| Closed | -$357K | – | 726 |
|
|
2014
Q2 | $357K | Buy |
+5,734
| New | +$357K | ﹤0.01% | 553 |
|
|
2014
Q1 | – | Sell |
-14,603
| Closed | -$1.03M | – | 746 |
|
|
2013
Q4 | $1.03M | Sell |
14,603
-2,615
| -15% | -$184K | ﹤0.01% | 284 |
|
|
2013
Q3 | $1.24M | Sell |
17,218
-2,037
| -11% | -$147K | ﹤0.01% | 243 |
|
|
2013
Q2 | $1.07M | Buy |
+19,255
| New | +$1.07M | ﹤0.01% | 229 |
|